Navigation Links
Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
Date:11/10/2008

ods sold 136.5 162.0

Rental expenses 52.9 50.6

Total cost of revenues 189.4 212.6

Gross profit

Capital sales 93.0 114.6

Rental revenues 59.0 44.8

Total gross profit 152.0 159.4

As a percentage of sales 44.5% 42.8%

Operating expense 126.3 125.7

As a percentage of sales 37.0% 33.8%

Litigation and special (charges)/credits, net (2.3) 1.6

Operating profit 23.4 35.3

Other income/(expense), net (2.8) (2.2)

Income tax expense (1) 8.2 8.7

Income from continuing operations $12.4 $24.4

Diluted earnings per share:

Earnings per share from continuing

operations $0.20 $0.39

Average common shares outstanding -

diluted (thousands) 62,403 62,393

Dividends per common share $0.2850 $0.2850

Consolidated Cash Flows from

Operations (2)

Cash flow from operations $120.1 $88.5

Less: capital expenditures (26.0) (34.6)

Consolidated free cash flow $94.1 $53.9

Cash and cash equivalents $125.5 $81.5

Investment securities (3) $164.3 $112.8

Hill-Rom Capital Expenditures $23.7
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
2. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
3. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
4. BMP Sunstone Reports Third Quarter 2008 Financial Results
5. Endocare Reports Financial Results for Third Quarter 2008
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Isis Reports Financial Results and Highlights for Third Quarter of 2008
8. OncoGenex Reports Third Quarter Financial Results
9. American Oriental Bioengineering Reports Third Quarter 2008 Financial Results
10. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
11. Dendreon Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 US-Australian drug ... and its subsidiary, CanTx, Inc., and Yale University, on ... Cantrixil. The data was presented as an oral presentation ... Yale Medical School to the 62 nd Annual ... San Francisco, CA. ...
(Date:3/30/2015)... March 30, 2015    Intrexon Corporation ... biology, and Merck Serono, the biopharmaceutical business of ... today announced an exclusive strategic collaboration and license ... T-cell (CAR-T) cancer therapies. This collaboration advances Merck ... that modulate the immune system,s natural ability to ...
(Date:3/30/2015)... , March 30, 2015 ... biological drugs to treat cancer, viral infections and ... Sir John Bell , the Regius Professor ... the Office for the Strategic Coordination of Health ... effect.      (Photo: http://photos.prnewswire.com/prnh/20150330/736483 ...
(Date:3/30/2015)... and MADISON, Wis. , March 30, ... ,) (TSE: 4901) ("Fujifilm") and Cellular Dynamics International, Inc. ... ) ("CDI"), a leading developer and manufacturer of fully ... today announced that the two companies have entered into ... an all-cash tender offer to be followed by a ...
Breaking Biology Technology:Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8
... Capital Growth and Research held their conference at Grainger Hall. ... way to attract venture capital to Wisconsin, according to the ... conference on Friday at UW-Madisons Grainger Hall. , ,We believe ... John Neis , a senior partner at Venture ...
... are entering into a major war. We must take ... we have already entered a new front line where ... this brand-new mega-search-engine-driven e-commerce marketplace. , ,E-commerce is causing ... the front lines know exactly who is winning and ...
... Communications , a Minnesota firm that makes networking products ... InfiniBand market. InfiniBand, a type of low-latency network, is ... it an edge over Ethernet. , ,For Small Tree, ... Apple market, the product represents a new direction. , ...
Cached Biology Technology:Wisconsin investors seek regional partners and informed legislature 2Wisconsin investors seek regional partners and informed legislature 3Global branding is now a war 2Global branding is now a war 3Global branding is now a war 4Small Tree brings InfiniBand to Apple Xserve G5 clusters 2Small Tree brings InfiniBand to Apple Xserve G5 clusters 3
(Date:3/17/2015)... 17, 2015 Emotient, the leader in ... announced general availability of Emotient Analytics , ... analysis of facial expressions. The system analyzes videos ... products and services. It delivers audience response metrics ... - as derived from facial evidence of emotional ...
(Date:3/12/2015)... , March 12, 2015 ... a standardized identity and access management (IAM) solution ... implementation schedule. With Beta System,s new IAM package, ... best practices gleaned from multiple IAM implementations across ... the software as well as any necessary services ...
(Date:3/10/2015)... 10, 2015 Transforming How We ... "Personalized Medicine in Human Space Flight" by ... Goodwin , Ph.D. was recently featured by Springer Science ... years. Specifically, "Personalized Medicine in Human Space ... published in 2013 and 2014 from Springer in the ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... you a healthy tan. The study, led by Dr Ian Stephen ... rich in fruit and vegetables gives you a more healthy golden ... of heading for the sun the best way to look good ... the journal Evolution and Human Behaviour . Dr Ian ...
... Nine researchers from Iowa State University two of them ... Laboratory have been named fellows of the American Association ... AAAS fellows and their award citations are: ... Munas Mehl Professor of Computer Engineering, "For distinguished contributions to ...
... "Substances that appear at first glance to be harmless ... form new, allergenic substances from them, giving rise to ... isothiocyanates, which are formed on the skin following repeated,contact ... Chemistry at the University of,Gothenburg. Around one in ...
Cached Biology News:Looking good on greens 2AAAS honors Iowa State, Ames Lab researchers for distinguished science 2Knee protectors can form allergenic substances on the skin 2
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
AK6 Antibody...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
Goat polyclonal to Rabenosyn 5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: ELKHTLAKQKGGTD, corresponding to C terminal amino acids 771-784 of Human Rabenosyn 5. Entr...
Biology Products: